Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

A 23-year-old graduate student is evaluated in the ambulatory care clinic due to bothersome facial hair and infrequent menstrual periods. Her menarche occurred at age 12, and she reports having only three to four menses per year since that time. Over the last 24 months, she has observed increasing coarse, dark hair on her upper lip, chin, and lower abdomen, prompting her to shave frequently. Her past medical history is unremarkable, and she takes no medications. Vital signs show a blood pressure of 118/76 mmHg118/76 \text{ mmHg}, a pulse of 74/min74/\text{min}, and a respiratory rate of 14/min14/\text{min}. Her body mass index is 29 kg/m229 \text{ kg/m}^2. Physical examination confirms moderate inflammatory acne over the face and back, as well as terminal hairs in a male-pattern distribution. Pelvic examination is normal, with no evidence of clitoromegaly or palpable adnexal masses. A urine human chorionic gonadotropin test is negative. Laboratory results show normal serum thyroid-stimulating hormone and prolactin levels. Which of the following is the most appropriate next step in management?

  1. A
    Prescription of combined oral contraceptives
  2. B
    Endometrial biopsy
  3. Measurement of serum 17-hydroxyprogesteroneCevap
  4. D
    Measurement of serum luteinizing hormone and follicle-stimulating hormone
  5. E
    Oral glucose tolerance test

Cevap

Measurement of serum 17-hydroxyprogesterone
The correct answer is measurement of serum 17-hydroxyprogesterone. This patient presents with oligo-ovulation and clinical hyperandrogenism, making polycystic ovary syndrome (PCOS) the most likely diagnosis. However, PCOS is a diagnosis of exclusion. Before confirming PCOS, other causes of hyperandrogenism must be ruled out, including non-classic congenital adrenal hyperplasia (NCCAH), thyroid dysfunction, and hyperprolactinemia. Since thyroid-stimulating hormone and prolactin levels are already normal, checking 17-hydroxyprogesterone is required to exclude NCCAH (late-onset 21-hydroxylase deficiency).

Adım Adım Çözüm

1
Identify the primary clinical presentation and generate a differential diagnosis.
The patient exhibits oligo-ovulation (irregular menses) and clinical hyperandrogenism (hirsutism, acne), pointing to polycystic ovary syndrome (PCOS) as the most likely diagnosis.
Establishing the core symptoms is necessary to guide the diagnostic workup according to standard endocrine protocols.
2
Apply diagnostic criteria and identify necessary exclusion tests.
PCOS is a diagnosis of exclusion. Pregnancy, thyroid disorders, and hyperprolactinemia have already been excluded by normal initial laboratory results.
The Rotterdam criteria require the exclusion of other medical conditions that can cause hyperandrogenism and irregular menses before confirming PCOS.
3
Select the appropriate laboratory test to rule out remaining diagnostic mimics.
Non-classic congenital adrenal hyperplasia (NCCAH) must be excluded by measuring serum 17-hydroxyprogesterone.
NCCAH, primarily caused by late-onset 21-hydroxylase deficiency, presents identically to PCOS and is a critical condition to rule out.

Anahtar Kavram

Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion; confirming the diagnosis requires ruling out mimics such as thyroid dysfunction, hyperprolactinemia, and non-classic congenital adrenal hyperplasia (via 17-hydroxyprogesterone testing).
Bu soruyu puanla